[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-344680-105":59,"doc-detail-344680-en":131},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":124,"head_meta":126,"extra_data":128,"updated_unix":130},105,"en","methylation-specific-universal-and-highly-sensitive-identification-of-ctdna-in-prostate-cancer-by-multiplex-droplet-digital-pcr","Methylation-specific, universal, and highly sensitive identification of ctDNA in prostate cancer by multiplex droplet digital PCR","","Liquid biopsy for circulating tumor DNA (ctDNA) enables non-invasive, real-time monitoring in cancer. This study develops a universal, one-tube methylation-specific multiplex droplet digital PCR (mm-ddPCR) assay to detect ctDNA in plasma from metastatic prostate cancer patients. Public array data identify prostate tissue methylation signatures. Multiplexing targets three novel genomic regions plus two previously reported prostate cancer biomarkers and a reference gene. The assay detects five ctDNA biomarkers in mCRPC plasma with 95% confidence and supports rapid, sensitive, universal biomarker detection.",{"@graph":69,"@context":123},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/methylation-specific-universal-and-highly-sensitive-identification-of-ctdna-in-prostate-cancer-by-multiplex-droplet-digital-pcr/344680/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/methylation-specific-universal-and-highly-sensitive-identification-of-ctdna-in-prostate-cancer-by-multiplex-droplet-digital-pcr/344680.png","ImageObject",300,407,{"name":92,"@type":93},"Himbo","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-28","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",14,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119],{"name":110,"@type":111,"acceptedAnswer":112},"What was the objective of the study?","Question",{"text":113,"@type":114},"To develop a universal and highly sensitive one-tube methylation-specific multiplex ddPCR assay that can detect ctDNA in plasma from metastatic prostate cancer patients.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"How was the multiplex ddPCR assay designed?",{"text":118,"@type":114},"Publicly available array data were used to identify prostate tissue methylation signatures, and the assay was implemented as a methylation-specific multiplex ddPCR using a Bio-Rad QX600 multiplexing platform with tissue and plasma samples analyzed.",{"name":120,"@type":111,"acceptedAnswer":121},"Which ctDNA biomarkers were detected using the assay?",{"text":122,"@type":114},"The assay targeted three novel regions (ACTRT2, EVX1, HOXD13) plus two previously reported prostate cancer-specific hypermethylated CpG biomarkers (DOCK2, HAPLN3) and an ALB reference gene.","https://schema.org",{"og:url":83,"og:type":125,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":127,"canonical":83},"index,follow",{"doc_id":129,"site_id":62},344680,1790214766,{"code":4,"msg":5,"data":132},{"doc_id":129,"user_id":133,"nickname":92,"user_avatar":134,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":140,"language":141,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":67,"update_tm":145,"read_time":146,"preview_page_count":19,"preview_urls":147},687197100911,"https://ap-avatar.wpscdn.com/avatar/a000239b6f1da00475?x-image-process=image/resize,m_fixed,w_180,h_180&k=1785132997149421697","OPEN ACCESS  \nCitation: Kahns S, Zedan AH, Aagaard MM, Canto LMD, Kjær-Frifeldt S, Eriksen SV, et al.(2026) Methylation-specific, universal, and highly sensitive identification of ctDNA in prostate cancer by multiplex droplet digital PCR. PLoS One 21(1): e0340786. [https://doi](https://doi). org/10.1371/journal.pone.0340786  \nEditor: Mohamed Gouda, The University of Texas MD Anderson Cancer Center, UNITED STATES OF AMERICA  \nReceived: July 8, 2025  \nAccepted: December 27, 2025  \nPublished: January 29, 2026  \nCopyright: © 2026 Kahns et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.  \nData availability statement: Yes-all data are fully available without restriction; All relevant data are within the paper and its Supporting  information files.  \nRESEARCH ARTICLE  \nMethylation-specific, universal, and highly sensitive identification of ctDNA in prostate cancer by multiplex droplet digital PCR  \nSøren Kahns1*, Ahmed H. Zedan2, Mads M. Aagaard3, Luisa M. D. Canto1,2, Sanne Kjær-Frifeldt4, Stine V. Eriksen2, Christine V. Madsen2, Jonna S. Madsen1,5, Palle J. S. Osther5,6, Torben F. Hansen2,5, Rikke F. Andersen1,2  \n1 Department of Biochemistry and Immunology, Vejle Hospital, University Hospital of Southern Denmark, Vejle, Denmark, 2 Department of Oncology, Vejle Hospital, University Hospital of Southern Denmark, Vejle, Denmark, 3 Department of Genetics, Vejle Hospital, University Hospital of Southern Denmark, Vejle, Denmark, 4 Department of Pathology, Vejle Hospital, University Hospital of Southern Denmark, Vejle, Denmark, 5 Department of Regional Health Research, Faculty of Health Sciences, University of Southern Denmark, Odense, Denmark, 6 Department of Urology, Vejle Hospital, University Hospital of Southern Denmark, Vejle, Denmark  \n* [soren.kahns@rsyd.dk](soren.kahns@rsyd.dk)  \nAbstract  \nObjective  \nLiquid biopsy for detection of circulating tumor DNA (ctDNA) offers a promising, non-invasive strategy for real-time monitoring of cancer. We aimed to develop a universal and sensitive one-tube droplet digital PCR (ddPCR) multiplex assay able to detect ctDNA in plasma from metastatic prostate cancer (PCa) patients.  \nMethods  \nPublicly available array data are applied to identify methylation signatures specific to both normal and cancerous prostate tissue. The assay is based on the highly sensitive ddPCR technology, and tissue and plasma samples are analyzed using the QX600 ddPCR multiplexing platform from BioRad.  \nResults  \nWe identified three novel genomic regions, ACTRT2 , EVX1, and HOXD13 , containing CpG-methylation signatures specific to normal and cancerous prostate tissue. We successfully targeted the three biomarkers in a single-tube methylation-specific multiplex ddPCR (mm-ddPCR) assay along with two previously reported PCa-specific hypermethylated CpG biomarkers, DOCK2 and HAPLN3 , and the ALB reference gene. The mm-ddPCR assay consistently detected ACTRT2 , EVX1, and HOXD13 across all samples originating from prostate-derived tissue. In contrast, the HAPLN3 and DOCK2 biomarkers were predominantly detected in PCa tissue. We also  \nPLOS One | [https://doi.org/10.1371/journal.pone.0340786](https://doi.org/10.1371/journal.pone.0340786) January 29, 2026 1 / 13  \nFunding: The author(s) received no specific funding for this work.  \nCompeting interests: The authors have declared that no competing interests exist.  \ndemonstrate that the five ctDNA biomarkers can be detected in plasma samples from metastatic castration-resistant PCa (mCRPC) patients with a 95% CI (85%, 100%) using the mm-ddPCR assay.  \nConclusion  \nThis work demonstrates that the mm-ddPCR assay offers a simple, fast, costeffective, sensitive, and universal tool for the detection of ctDNA biomarkers in plasma from mCRPC patients. Further studies are required to explore its p","cbCaiiqU3DA8rokV","https://ap.wps.com/l/cbCaiiqU3DA8rokV","pdf",747436,13,"English","# Abstract\n## Objective\n## Methods\n## Results\n## Conclusion\n# Introduction","[{\"question\":\"What was the objective of the study?\",\"answer\":\"To develop a universal and highly sensitive one-tube methylation-specific multiplex ddPCR assay that can detect ctDNA in plasma from metastatic prostate cancer patients.\"},{\"question\":\"How was the multiplex ddPCR assay designed?\",\"answer\":\"Publicly available array data were used to identify prostate tissue methylation signatures, and the assay was implemented as a methylation-specific multiplex ddPCR using a Bio-Rad QX600 multiplexing platform with tissue and plasma samples analyzed.\"},{\"question\":\"Which ctDNA biomarkers were detected using the assay?\",\"answer\":\"The assay targeted three novel regions (ACTRT2, EVX1, HOXD13) plus two previously reported prostate cancer-specific hypermethylated CpG biomarkers (DOCK2, HAPLN3) and an ALB reference gene.\"}]","Methylation-specific, universal, and highly sensitive identification of ctDNA in prostate cancer by multiplex droplet digital PCR | PDF",1790054892,33,[148,152,156,160],{"page_no":8,"url":149,"width":150,"height":151},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/267540b29db7d0df9f0e1e547b85d2b5.webp",983,1272,{"page_no":14,"url":153,"width":154,"height":155},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/3cf944e3a77e63bb529231ab8524a984.webp",982,1270,{"page_no":81,"url":157,"width":158,"height":159},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/35df57688033cac63ce20da81d3f9ec2.webp",981,1269,{"page_no":19,"url":161,"width":162,"height":163},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/2e8b690bb3eea0bf93579de9d19e4089.webp",980,1268]